The primary purpose of the Preclinical Development Lead in Cell and Gene Therapies (CGT) will be to play a leading role in developing and executing the nonclinical strategy in support of Astellas CGT programs. The successful candidate will directly influence the discovery and development of cell and AAV-based gene therapies by designing, overseeing, and interpreting in vivo and in vitro studies. The incumbent will be the primary driver of Research Program Teams spanning discovery through IND/CTA submissions. This is a hybrid role that has no laboratory responsibilities. In addition, the Preclinical lead will draft nonclinical sections of regulatory submission documents. The successful candidate will partner with other scientists, clinicians, and external experts to advance transformational treatments for patients with severe diseases.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees